Caldera wins FDA nod for vaginal mesh alternative; Boston Scientific rolls out new pacers;

@FierceMedDev: Activaero readies for hoped-for EU launch of its first drug/device treatment. Editor's corner | Follow @FierceMedDev

@DamianFierce: Delcath is axing 20% of its workforce after the FDA frowned upon its cancer-treating device. News | Follow @DamianFierce

> In a new study, 2012 Fierce 15 winner Tyrx reported that its antibacterial envelope reduced major infection rates by 100% in patients receiving cardiac implants. News

> Caldera Medical won FDA clearance for Vertessa Lite, a polypropylene mesh used in abdominal sacrocolpopexy procedures designed to treat pelvic organ prolapse. More

> Bausch + Lomb won Canadian approval for its Victus laser eye surgery system, which handles cataract and corneal procedures. Release

> Michigan's Tangent Medical has launched U.S. commercialization of NovaCath, an IV catheter equipped with stabilization, passive needle encapsulation, tubing management and blood control. Item

> Boston Scientific ($BSX) has launched a new line of pacemakers in Europe, saying the devices provide valuable monitoring capabilities to manage patients with co-morbidities. Story

> In response to the global concern over Middle East Respiratory Syndrome Coronavirus, Life Technologies ($LIFE) is touting its Applied Biosystems 7500 Fast Dx Real-Time PCR instrument as ideal for analysis of assays for the virus. News

Biotech News

@FierceBiotech: Where were the breakthrough drugs for diabetes at ADA 2013? Editor's corner | Follow @FierceBiotech

 @JohnCFierce: Have to wonder how PTC's IPO will come out as questions are raised about its lead obsession, um, program. Article | Follow @JohnCFierce

@RyanMFierce: Verastem launching a PhI for second FAK inhibitor in pipeline. | Follow @RyanMFierce

 @EmilyMFierce: And back to biotech... Genetic biomarkers could help tailor breast cancer therapies. Article | Follow @EmilyMFierce

> Roche, AstraZeneca join forces on precompetitive R&D initiative. More

> Delcath slashes U.S. staff by 20% after FDA-panel disaster. Story

Pharma News

@FiercePharma: U.K. cost agency recommends Bayer's Xarelto to prevent potentially fatal blood clots in the lungs and legs. More | Follow @FiercePharma

@EricPFierce: Ranbaxy gets some support from India's Supreme Court as company faces down concerns there. Item | Follow @EricPFierce

@CarlyHFierce: Proxy fight heating up at Vivus... First Manhattan announces search for new CEO candidates. Report | Follow @CarlyHFierce

> Spain sugarcoats pharma-purchasing medicine with payment guarantee. Story

> Sanofi, Novartis, GlaxoSmithKline reportedly circling India's Elder Pharma. More

Biomarkers News

> Arizona's TGen and Ventana Medical Systems partner to find cancer biomarkers. News

> New diagnostic IDs patients unlikely to benefit from chemoradiation. Item

> Traumatic brain injury biomarker company raises $6M for diagnostic. Item

> HPV antibodies point researchers to high risk for oral cancer. Story

> Brain scan may provide biomarker guideposts to ideal depression treatment. Article

Drug Delivery News

@MichaelGFierce: Trending right now at FierceDrugDelivery: Insulin delivery devices at ADA 2013. Roundup | Follow @MichaelGFierce

> Acorda reports positive data for epilepsy nasal spray. Item

> Alnylam posts positive preclinical RNAi delivery results for fatal conditions. Article

> Roundup: Insulin delivery devices at ADA. Story

> Microbubbles for imaging offer targeted drug-delivery approach. More

> Peptide-coated nano-gold shows cancer-fighting promise. Report

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.